Table 2 Relationship between NEIL3 expression and clinicopathology in our LUAD cohort
From: NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma
Characteristics | n | NEIL3 | χ2 | P value | |
|---|---|---|---|---|---|
Low expression | High expression | ||||
Total | 406 | 228 | 178 | Â | Â |
Age | 1.082 | 0.298 | |||
 ≤ 60 | 146 | 77 (52.74) | 69 (47.26) |  |  |
 > 60 | 260 | 151 (58.08) | 109 (41.92) |  |  |
Gender | 2.814 | 0.093 | |||
 Male | 249 | 148 (59.44) | 101 (40.56) |  |  |
 Female | 157 | 80 (50.96) | 77 (49.04) |  |  |
TNM stage | 1.81 | 0.178 | |||
 I and II | 312 | 169 (54.17) | 143 (45.83) |  |  |
 III and IV | 94 | 59 (62.77) | 35 (37.23) |  |  |
Tumor stage | 14.648 | 0.002* | |||
 I | 203 | 124 (61.08) | 79 (38.92) |  |  |
 II | 145 | 81 (55.86) | 64 (44.14) |  |  |
 III | 32 | 8 (25.00) | 24 (75.00) |  |  |
 IV | 26 | 15 (57.69) | 11 (42.31) |  |  |
Metastasis stage | 0.001 | 0.971 | |||
 Negative | 397 | 223 (56.17) | 174 (43.83) |  |  |
 Positive | 9 | 5 (55.56) | 4 (44.44) |  |  |
Node stage | 0.88 | 0.348 | |||
 Negative | 222 | 120 (54.05) | 102 (45.94) |  |  |
 Positive | 184 | 108 (58.70) | 76 (41.30) |  |  |